Leflunomide as adjuvant treatment of dermatomyositis

Journal of the American Academy of Dermatology

Volumn 58, Issue 3, 2008, Pages 403-406

  Boswell, J Scott ^a   Costner, Melissa I ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DAPSONE; FLUOCINONIDE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNISONE;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; HUMAN; INFECTION; MAINTENANCE THERAPY; MALE; NAUSEA; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; DERMATOLOGIC AGENTS; DERMATOMYOSITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROXYCHLOROQUINE; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; TREATMENT OUTCOME;

EID: 39149095619     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.08.014     Document Type: Article

References (29)

1. Smolen J.S., Kalden J.R., Scott D.L., Rozman B., Kvien T.K., Larsen A., et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomized, multicenter trial; European leflunomide study group. Lancet 353 (1999) 259-266
2. Strand V., Cohen S., Schiff M., Weaver A., Fleischmann R., Cannon G., et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate; leflunomide rheumatoid arthritis investigators group. Arch Intern Med 159 (1999) 2542-2550
3. Kremer J., Genovese M., Cannon G.W., Caldwell J., Cush J., Furst D.E., et al. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. J Rheumatol 31 (2004) 1521-1531
4. Dalakas M.C., and Hohlfeld R. Polymyositis and dermatomyositis. Lancet 362 (2003) 971-982
5. Sontheimer R.D. The management of dermatomyositis: current treatment options. Expert Opin Pharmacother 5 (2004) 1083-1099
6. Xu X., Williams J.W., Bremer E.G., Finnegan A., and Chong A.S. Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem 270 (1995) 12398-12403
7. Breedveld F.C., and Dayer J.M. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis 59 (2000) 841-849
8. Frieling U., and Luger T.A. Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases. Clin Exp Dermatol 27 (2002) 562-570
9. Kaltwasser J.P., Nash P., Gladman D., Rosen C.F., Behrens F., Jones P., et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 50 (2004) 1939-1950
10. Tlacuilo-Parra J.A., Guevara-Gutierrez E., Rodriguez-Castellanos M.A., Ornelas-Aguirre J.M., Barba-Gomez J.F., and Salazar-Paramo M. Leflunomide in the treatment of psoriasis: results of a phase II open trial. Br J Dermatol 150 (2004) 970-976
11. Schmitt J., Wozel G., and Pfeiffer C. Leflunomide as a novel treatment option in severe atopic dermatitis. Br J Dermatol 150 (2004) 1182-1185
12. Majithia V., Sanders S., Harisdangkul V., and Wilson J.G. Successful treatment of sarcoidosis with leflunomide. Rheumatology (Oxford) 42 (2003) 700-702
13. Nousari H.C., and Anhalt G.J. Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent. Arch Dermatol 136 (2000) 1204-1205
14. Rozman B. Clinical pharmacokinetics of leflunomide. Clin Pharmacokinet 41 (2002) 421-430
15. van Riel P.L., Smolen J.S., Emery P., Kalden J.R., Dougados M., Strand C.V., et al. Leflunomide: a manageable safety profile. J Rheumatol Suppl 71 (2004) 21-24
16. van Roon E.N., Jansen T.L., Houtman N.M., Spoelstra P., and Brouwers J.R. Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity. Drug Saf 27 (2004) 345-352
17. Holm E.A., Balslev E., and Jemec G.B. Vasculitis occurring during leflunomide therapy. Dermatology 203 (2001) 258-259
18. Chan A.T., Bradlow A., and McNally J. Leflunomide induced vasculitis-a dose-response relationship. Rheumatology (Oxford) 42 (2003) 492-493
19. Chan J., Sanders D.C., Du L., and Pillans P.I. Leflunomide-associated pancytopenia with or without methotrexate. Ann Pharmacother 38 (2004) 1206-1211
20. Bharadwaj A., and Haroon N. Peripheral neuropathy in patients on leflunomide. Rheumatology (Oxford) 43 (2004) 934
21. Bonnel R.A., and Graham D.J. Peripheral neuropathy in patients treated with leflunomide. Clin Pharmacol Ther 75 (2004) 580-585
22. Carulli M.T., and Davies U.M. Peripheral neuropathy: an unwanted effect of leflunomide?. Rheumatology (Oxford) 41 (2002) 952-953
23. Takeishi M., Akiyama Y., Akiba H., Adachi D., Hirano M., and Mimura T. Leflunomide induced acute interstitial pneumonia. J Rheumatol 32 (2005) 1160-1163
24. Kamata Y., Nara H., Kamimura T., Haneda K., Iwamoto M., Masuyama J., et al. Rheumatoid arthritis complicated with acute intersitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 43 (2004) 1201-1204
25. Soliotis F., Glover M., and Jawad A.S. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis 61 (2002) 850-851
26. Fischer T.W., Bauer H.I., Graefe T., Barta U., and Elsner P. Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide. Dermatology 207 (2003) 386-389
27. Kerr O.A., Murray C.S., and Tidman M.J. Subacute cutaneous lupus erythematosus associated with leflunomide. Clin Exp Dermatol 29 (2004) 319-320
28. Goeb V., Berhelot J.M., Joly P., Mejjad O., de Quartrebarbes J., Reynaud-Hautin C., et al. Leflunomide-induced subacute cutaneous lupus erythematosus. Rheumatology (Oxford) 44 (2005) 823-824
29. Gensburger D., Kawashima M., Marotte H., Kanitakis J., and Miossec P. Lupus erythematosus with leflunomide: induction or reactivation?. Ann Rheum Dis 64 (2005) 153-155